Home|Journals|Articles by Year|Audio Abstracts
 

Original Article

J App Pharm Sci. 2016; 6(10): 098-101


Drug Utilization Evaluation of Anticancer Drugs in a Tertiary Care Teaching Hospital: a Descriptive Observational Study

Vinodkumar Mugada, Aswinichand Paruchuri, Mounika Munagala.




Abstract

Drug Utilization Evaluation(DUE) promotes rational use of drugs.The aim of present study was to conduct DUE of anticancer drugs. Newly diagnosed and/or known case of carcinoma which required treatment with chemotherapy, patients of both sex, and age >18 years were included in the study. Patients diagnosed as having carcinoma that also required surgical intervention, radiotherapy or other modality of management were excluded from the study.WHO core prescribing indicators are used to know about polypharmacy,excessive use of antibiotics, percentage of drugs prescribed by from Essential Drugs List(EDL).Females were commonly affected than males. Patients of age group 41-50 years (mean 52.43, SD ±7.77) constituted the highest number, 34% and 13% in rural and urban population respectively. 5-Flurouracil and Cisplatin are most commonly prescribed anticancer drugs followed by Cyclophosphamide. The most commonly used adjuvant drugs in our study are Diclofenac,B-Complex, Granisetron, Ranitidine,Dexamethasone,Ondansetron, and Mannitol. The cytoprotectant drugs observed in our study are Leucovorin, Mesna and Peg- Filgrastim. Average number of Cytotoxic Drugs per prescription was 1.97. Average number of Drugs per prescription was 8.16.Percentage of drugs prescribed from essential drugs list was 88.4%. Percentage of encounters with an antibiotic prescribed was 54.8%. Polypharmacy, unnecessary antibiotic and injection prescribing were not observed.The percentage of drugs from EDL may be improved.

Key words: Drug Utlization Evaluation, Essential Drugs List,WHO core prescribing indicators,Polypharmacy,rational.






Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Refer & Earn
JournalList
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.